% | $
Quotes you view appear here for quick access.

ЕЛН Message Board

bocamp1 246 posts  |  Last Activity: 19 minutes ago Member since: Oct 13, 1998
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Is this not true?

    by gkas711 Aug 28, 2015 2:23 PM
    bocamp1 bocamp1 Aug 29, 2015 3:56 PM Flag

    Sno, thats about the 100th post saying the same thing. Again, we get it, you are worried. Nobody cares about your anxieties. You didnt seem to have any at 50 cents(your last purchase; or so you say). Why do you feel it necessary to display your obsessive compulsions endlessly here. Give us a break and take a couple valium and disappear for a while.
    Again sno's implied negative bias, along with his "purchases", point to very good things ahead. This is the same guy who was bashing the stock, and didnt see the risk/reward at a dime.L0l Yea, i might listen to his concerns.............................................

  • Reply to

    new abstract in liver

    by snogreen Aug 28, 2015 9:41 AM
    bocamp1 bocamp1 Aug 28, 2015 11:44 AM Flag

    The liver is a huge potential market. Nonalcoholic steatohepatitis and other diseases of the liver characterized by tissue fibrosis is mostly unmet right now. The fatty liver diseases has no treatment, other than diet, but most americans just cant do that. So 2 bios with no revs have some potential in the liver area and have on going trials only; ICPT(market cap 4.6 BILLION) and LJPC(market cap 1/2 Billion). As always, great potential with rgrx

  • Free advice from expert donk is worth exactly what it costs. Keep up the good work donk. See you at a buck

    Koreans and Chinese should have consulted with Donk & Donk before commiting to TB4 and RGRX.
    Gtree has bet their whole existence on TB4 and gotten miilions from the Korean government, but will lose all because they did not consult with expert message board patent attorney..... the donk
    When will they learn..........................?

  • Amazing all the stock that has been sold recently. You would expect some kind of bounce but it just doesnt come.
    Stock oversold but goes nowhere.

  • Reply to

    The Elephant in the MIDDLE OF THE ROOM.......

    by donker3 Aug 27, 2015 11:59 AM
    bocamp1 bocamp1 Aug 27, 2015 12:43 PM Flag

    Yes, elephant in the room for sure, but its not patents, its the Donk who miraculously appears after a long absence on the day the stock is attacked by the shorts. What a coincidence. And he appears to enlighten us, once again, on a patent problem. A problem that neither china(delay from manufacturing issues; china is a dysfuntional partner at best) nor Korea seemed concerned about.
    Sept here soon enough, along with details of Korean trials. Buy the weakness..............right sno????? No, better to wait when all details are positively known. Buy high, Now thats investing.........

  • Sno says he bought at the offer of 50 about a week ago. But, doesnt see the value now paying the .395 offer? Nothing has changed in this last week. But his posts since the "50 cent purchase" have become decidedly negative. This is classic[

  • Reply to


    by snogreen Aug 27, 2015 10:03 AM
    bocamp1 bocamp1 Aug 27, 2015 10:15 AM Flag

    You cant stop bashing JJ? What purpose does this serve to say the same thing everyday?. It certainly is not the type of post that fits with a long agenda. Again, sno's bizzare money losing agenda is only known to him. Only one thing is certain, he will repeat the same message over and over..........................

  • He posted news on NK trial which isnt due till sept. He has only posted that one time. Cant find anything to support that post. Stock had no reaction at all. JJ has not PR'd, and you know he would. As sno says, not on clinical gov site. Not on Gtree english webpage.
    Anyone verify?

  • Reply to

    6 Cents bo.

    by snogreen Aug 26, 2015 4:54 PM
    bocamp1 bocamp1 Aug 26, 2015 5:07 PM Flag

    You need to calm down. No need for captal letters, sno. You are getting a little hysterical.
    The basic point here is that you always seem to say you are long and indeed have recently bought, but then turn on a negative bias (history shows rgrx flops design). This has been your mo for some time. Your agenda is your own and going against your bias has proven always to be a successful investment stategy. Keep up the good work.

  • Reply to


    by trotupinfront Aug 25, 2015 6:47 PM
    bocamp1 bocamp1 Aug 26, 2015 4:09 PM Flag

    I cant even bother to read your nonsense. MEGO.. Who cares about buying at 6 cents? Are you high?? I sure care and B7 cares.
    You are clueless as to bio partnerships or license deals. If koreans do not want rgrx to release any data. They will not. There is precident in many deals. Your problem(one of many) is you have no similar experience in the bio world. The one who pays the bills, dictates the terms and data release.
    You need to stop and think, if that is even possible for you. Remember your quick wrong post a short time ago about rgrx being immimently put into the bio index? How wrong was that? DUH?
    Give me a couple examples here about you being right about anything here???

  • Reply to


    by trotupinfront Aug 25, 2015 6:47 PM
    bocamp1 bocamp1 Aug 26, 2015 12:52 PM Flag

    Yes, of course. But, please provide some examples and how he has help investors make money here. Was he pounding the table below 10 cents?(He has been consistently wrong on share price) Did he do well with scln? Was he right about the Koreans being small players and not having money to start trials? Was he right to focus on China? Could go on and on. All i can say is that whatever sno has been smoking these last few years, you must be into also. .
    Good Luck.

  • Reply to


    by trotupinfront Aug 25, 2015 6:47 PM
    bocamp1 bocamp1 Aug 26, 2015 11:45 AM Flag

    Man, you are relentless; like a child. You dont get it. Trials designs can not be released by Fink UNTIL the Koreans say so. They are running the show. All timing is up to them.

  • Reply to


    by trotupinfront Aug 25, 2015 6:47 PM
    bocamp1 bocamp1 Aug 26, 2015 11:18 AM Flag

    Sno, you are a broken record. Give it a rest. You ramblings are pointless. Trials are going forward, press releases to that effect soon, and designs will have doable endpoints. So, wait for all your baseless fears to be resolved and then buy more. Of course, you will end up paying 50+ cents.
    Try and find a stock, any stock, that has this type of positive divergence to this huge market selloff. Its not easy. Few real sellers here for a reason.

  • Reply to

    Estimation of efficacy of 273 in P2a

    by shortridge3w Aug 25, 2015 6:19 PM
    bocamp1 bocamp1 Aug 25, 2015 8:38 PM Flag

    I wouldnt worry about safety too much. The only other sigma 1 agonist that was approved was back in 2010. It was a drug owned by Avanir. It treats PBA in ALS and MS patients. It had a record of 60% AE's--fatigue, dizziness, muscle weakness, infections, nausea, dyspnoea, respiratory distress..........amazing. And it was approved without knowing the MOA. And it was their only drug and company was bought for 3.5 billion by Otsuka.
    AVXL's drug will have some AE's, but it wont matter in terms of approval if efficacy is maintained

  • Reply to

    Off the radar.........stock up, dow off 500?

    by bocamp1 Aug 21, 2015 5:54 PM
    bocamp1 bocamp1 Aug 25, 2015 5:16 PM Flag

    There has been some interesting buying in the sept calls lately. Today, one block of 160 of the sept 7 calls done at .4, which was the offer. Anyone know any possible event that might happen in the next month. I thought the amgen partnered drug would show results in the 4 Q?

  • Reply to

    good news on eye NK

    by snogreen Aug 25, 2015 9:30 AM
    bocamp1 bocamp1 Aug 25, 2015 9:52 AM Flag

    Sno, stop looking in the rear view mirror. Koreans are a serious partner(big plus there was the recent toning down of war footing between the north and south/could have been a disaster) and have hired scientists to run trials. They arent here to repeat some failed endpoints. Its their money, and JJ is not running trials.
    All things moving on time with Koreans.

  • Reply to

    From August 2011

    by slip_60 Aug 24, 2015 1:41 PM
    bocamp1 bocamp1 Aug 25, 2015 9:28 AM Flag

    Reseller..............can you say clueless?
    Management should really hire another mouthpiece for the company.

  • Reply to

    oil under $39/barrel

    by thebasiles777 Aug 24, 2015 7:38 AM
    bocamp1 bocamp1 Aug 24, 2015 2:01 PM Flag

    Gas prices, at the pump, is a function of oil prices and refinery capacity. You cant put the raw product in your car. Refinery capacity is the reason pump prices have stayed so high. The regulations that have prevented the building of new refineries and the silly EPA convoluted blending requirements, are the responsibility of the feckless Obama administration. Give credit where due. But, obama wants higher fossil fuels to futher his green agenda. He is also targeting nat gas, through more EPA regulations.

    1000 points off in the morning. It reminded me of the '87 crash. I was in the option pits of chicago at the time. EVeryone was printing money by selling puts. Needless to say, that ended that strategy, as well as many careers.
    Buying stock on bid today. Sept cant come soon enough......................good luck to us.

  • Creating buying opportunities. Stock on sale................................again

  • Reply to

    Just a few thoughts.

    by pj1020 Aug 21, 2015 5:40 PM
    bocamp1 bocamp1 Aug 21, 2015 6:02 PM Flag

    Looking for another acquisition? Where do you guys come from....pj, resell, chewy?
    The china acquisition was a total failure. And now this one adds rev as you say, but little else. You are in fantasy land if you think company can do another right now. This one will make or break vaso, and it will be a couple Q's before we know.
    PJ, nothing you or your buds have said over these many months has ever come to pass. You just hype nonsense and wishful thinking. As i said, stock could not break .22 and now is back to doing nothing for a long period of time............